Navigation Links
ThromboGenics NV Announces Business Update and Half Year Results 2009
Date:8/27/2009

30/06/2009 30/06/2008 Unaudited consolidated statement of financial position In '000 Euro - According to IFRS ASSETS: Property plant and equipment 960 934 Intangible Assets 7,756 - Goodwill 2,586 2,586 Fixed Assets: 11,302 3,520 Trade and other receivables 2,442 32,236 Investments 5,721 6,684 Cash and cash equivalents 46,866 33,614 Current Assets 55,029 72,534 Pension 73 39 Long-term Assets 73 39 Total Assets 66,404 76,093 EQUITY AND LIABILITIES Share capital 113,997 111,086 Share premium 15,907 15,733 Accumulated translation differences 39 13 Other reserves (20,235) (21,199) Retained earnings (48,622) (38,026) Equity attributable to equity holders of the parent 61,086 67,607 Minority interests - - Total Equity 61,086 67,607 Trade payables 4,246 7,380 Other short-term liabilities 1,072 1,106 Short-term liabilities 5,318 8,486 Total Equity and Liabilities
'/>"/>
SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ThromboGenics NV: Business Update
2. ThromboGenics Announces Business Update and 2008 Full Year Results
3. ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis
4. ThromboGenics N.V.: Business Update
5. ThromboGenics Announces Half Year Results 2008
6. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
7. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
8. ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
9. ThromboGenics N.V. - Business Update
10. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
11. ThromboGenics Announces 2007 Full Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)...  Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced ... II Small Business Innovation Research Grant (SBIR) valued ... Institute of Allergy and Infectious Diseases (NIAID) of ... the development of the Company,s aerosolized KL 4 ... acute and chronic/late-phase radiation-induced lung injury. The company ...
(Date:10/1/2014)... 2014  Spherix Incorporated (Nasdaq: SPEX) -- an intellectual property ... of intellectual property, announced today that the Markman ... in the U.S. District Court for the Northern ... been rescheduled for November 10, 2014.  This hearing ... Court Order setting the Markman date was received ...
(Date:10/1/2014)... September 30, 2014 The participants committed ... but to spending their own time adjusting, tweaking and ... complex designs were ready for judging. , “I enjoyed ... firm thought leader. “The entries showed a commendable ... physical characteristics of the print medium and the creativity ...
(Date:10/1/2014)... 30, 2014 New applications of structures ... have evolved in nature over millennia are featured in ... for applications in biophotonics in the October issue ... journal is published by SPIE, the international society for ... of the peer-reviewed articles are accessible via open access. ...
Breaking Biology Technology:Discovery Labs Receives SBIR Grant Valued up to $3.0 Million to Support Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives SBIR Grant Valued up to $3.0 Million to Support Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3Markman Hearing Date for VTech and Uniden Litigation Now Set for November 10, 2014 2Array Architects Challenges Staff to Create with 3D Printer 2Biomimetic and bioinspired materials enable new healthcare options, reports Journal of Biomedical Optics 2Biomimetic and bioinspired materials enable new healthcare options, reports Journal of Biomedical Optics 3
... /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" ... will be held on Tuesday, July 20, 2010 at ... located at Suite 310, 650 West Georgia Street, Vancouver, British ... of May 28, 2010 will be entitled to vote ...
... ... high performance, cost effective renewable materials for customers which reduce dependency on fossil ... delivering a broad portfolio of biomaterials and biofuels to global markets at the ... ...
... NEW YORK , June 28 /PRNewswire-Asia-FirstCall/ ... international biopharmaceutical company,with operations in the U.S. and China , announced ... with Russell Investments, reconstitution of,its comprehensive set of U.S. and global equity ... on http://www.russell.com . , ...
Cached Biology Technology:Dragon Pharma announces date of special meeting 2DuPont Leader: Global Demand for Renewable Innovations Growing 2DuPont Leader: Global Demand for Renewable Innovations Growing 3NeoStem Achieves New Milestone as Company Joins Russell 3000 Index 2NeoStem Achieves New Milestone as Company Joins Russell 3000 Index 3NeoStem Achieves New Milestone as Company Joins Russell 3000 Index 4
(Date:9/30/2014)... California, San Diego, have completed the first comprehensive numerical ... uses the pixels in an image as data points ... , The researchers, led by J.S. Chen, the William ... of Engineering at UC San Diego, presented their findings ... conference in Pittsburgh this month. Chen also gave a ...
(Date:9/30/2014)... do seedless watermelon, salmon, and strawberries all have in ... two sets of chromosomes and are diploid, these organisms ... sets of chromosomesseedless watermelon and salmon have 3 and ... While this might seem surprising, in fact most ... first discovered over a century ago, but only recently, ...
(Date:9/30/2014)... and Howard Hughes Medical Institute investigator, and Margarita ... in the 2014 round of grants from the ... (Brain Research through Advancing Innovative Neurotechnologies) Initiative for ... 30, provides more than $3 million in funding ... The BRAIN Initiative, launched last year, is a ...
Breaking Biology News(10 mins):First comprehensive meshfree numerical simulation of skeletal muscle tissue achieved 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 3Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 4Salk scientists receive $3 million for BRAIN Initiative grant 2
... ago, a tiny mayfly had a problem. Like most adult mayflies, ... no time to waste. She took her mating flight, got fertilized, and ... got stuck in some oozing tree sap and died, preserved for all ... It was a pretty rude ending to what was already going to ...
... COLUMBUS, Ohio Astronomers, research on celestial bodies ... Ohio State University astronomers are working with medical physicists ... treatment one that is intended to be tougher ... studying how chemical elements emit and absorb radiation inside ...
... Wiley of the National Oceanic and Atmospheric Administration (NOAA) and ... (Volume 148, Nos. 5-6) how humpback whales in the Gulf ... ( Megaptera novaeangliae ) are large baleen whales (up to ... dense concentrations, such as krill or herrings. Humpbacks ...
Cached Biology News:Ancient species of mayfly had short, tragic life 2Astronomers reach for the stars to discover new cancer therapy 2Astronomers reach for the stars to discover new cancer therapy 3Astronomers reach for the stars to discover new cancer therapy 4Humpback whales catch prey with bubble-nets 2
...
Pronase Reagent...
Rabbit polyclonal to ECSIT ( Abpromise for all tested applications). entrezGeneID: 51295 SwissProtID: Q96HQ7...
Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide...
Biology Products: